World
How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong
DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests to homes with just a tube of spit. But challenges with its business model and continued data privacy concerns for consumers have brought the company once valued at $6 billion to a valuation of nearly $0, with Nasdaq threatening to delist it. WSJ explains what went wrong with Wojcicki’s biotech business. 0:00 Home DNA testing 0:49 The rise of 23andMe 2:18 The turning point 4:03 23andMe’s fall 5:23 What’s next? What Went Wrong explores the challenging conditions and decisions that led to a company s downturn. #23andMe #DNA #WSJ :::: Visit my YouTube channel @ The Wall Street Journal ( [ 🔗 Click ‼️ ]] )
( 100 Page ) :: 🏠 61 62 63 64 65 66 67 68 69 70 71 ▶️ ⭕️
🌟 9
Top Chef VIP 3, Episodio 57: Se acaban los cupos
🌟 7
Top 10 Most-Outrageous Foods on #DDD with Guy Fieri | Diners, Drive-Ins and Dives
🌟 12
[ L I V E 🔴] NEW RANK 🎯 SESSION S40 🔥 [ KYA HAM LOG TOP 1 PAHUCH SAKTEY HAI]
🌟 11
Aaj Ki Taaza Khabar Live: Top 100 News Today | Breaking News | Top News
🌟 8
Breaking News LIVE | Top News of the Day | INDIA Alliance s Today LIVE TV